Business Analysis

Intensity Therapeutics Reports Second‑Quarter 2026 Results and Study Update

The biotechnology firm disclosed $9.5 million in cash, resumed enrollment in its soft tissue sarcoma trial, and restarted treatment in a breast cancer study.

PE

Public EquityAugust 11, 2026 · 4 min read

Intensity Therapeutics Reports Second‑Quarter 2026 Results and Study Update — company or subject photograph — Company or subject photograph for Intensity Therapeutics Reports Second‑Quarter 2026 Results and Study Update. media.licdn.com

Intensity Therapeutics Inc. (Nasdaq: INTS) released its financial results for the second quarter ended June 30, 2026, and issued a business update on August 11, 2026. The company reported cash and cash equivalents of $9.5 million at the end of the quarter, a figure that reflects the balance sheet position after a private‑placement financing completed earlier in the year.

The…

Public Equity subscribers

Continue reading with a digital subscription

Unlock original reporting on business, startups, venture capital, private equity, M&A, IPOs and AI. Payments will be activated after the business account is connected.

Create reader account Sign in

intensity therapeuticsinvincible-3invincible-4soft tissue sarcomatriple negative breast cancerclinical trialsbiotechnologynasdaqfinancial results

Reporting basis

Public Equity reviewed the following reporting material before independently writing this story.

PR Newswire2026-08-11
PR Newswire2026-08-11

Related intelligence

Appier Posts Record‑High Q2 Revenue and Profitability — company or subject photograph

Business

Appier Posts Record‑High Q2 Revenue and Profitability

The AI‑as‑a‑Service firm surpassed guidance, lifted full‑year outlook and posted a quarterly core free cash flow record.

August 14, 2026 · 3 min

SuperCom and IQSTEL Report Strong Q2 2026 Results, Highlighting Revenue Growth and EBITDA Expansion — company or subject photograph

Business

SuperCom and IQSTEL Report Strong Q2 2026 Results, Highlighting Revenue Growth and EBITDA Expansion

SuperCom posted record revenue and EBITDA for the second quarter, while IQSTEL announced a record first‑half revenue and plans to expand profitability through an upcoming acquisition.

August 14, 2026 · 4 min

Cineverse Reports 175% Revenue Surge in Fiscal Q1 2027 — company or subject photograph

Technology

Cineverse Reports 175% Revenue Surge in Fiscal Q1 2027

The streaming‑technology firm posted a $30.6 million top line, up 175% from the same period a year earlier, driven by new technology acquisitions and expanded advertising revenue.

August 14, 2026 · 4 min